RIPA, MARCO
 Distribuzione geografica
Continente #
EU - Europa 3.110
NA - Nord America 2.389
AS - Asia 2.286
SA - Sud America 429
Continente sconosciuto - Info sul continente non disponibili 191
AF - Africa 67
OC - Oceania 32
Totale 8.504
Nazione #
US - Stati Uniti d'America 2.229
RU - Federazione Russa 1.709
CN - Cina 705
SG - Singapore 685
IT - Italia 528
BR - Brasile 323
SE - Svezia 294
HK - Hong Kong 289
VN - Vietnam 189
BD - Bangladesh 145
DE - Germania 128
GB - Regno Unito 109
FR - Francia 104
CA - Canada 93
IN - India 71
FI - Finlandia 43
AR - Argentina 41
PL - Polonia 39
MX - Messico 35
NL - Olanda 34
AU - Australia 32
JP - Giappone 32
AT - Austria 30
ES - Italia 27
TR - Turchia 21
ZA - Sudafrica 21
PK - Pakistan 17
SA - Arabia Saudita 17
ID - Indonesia 16
CO - Colombia 15
IQ - Iraq 14
EC - Ecuador 13
IR - Iran 12
TN - Tunisia 12
UA - Ucraina 12
CL - Cile 10
BE - Belgio 9
MA - Marocco 9
PH - Filippine 9
VE - Venezuela 9
KR - Corea 8
PY - Paraguay 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
IE - Irlanda 7
LT - Lituania 7
LU - Lussemburgo 7
UZ - Uzbekistan 7
MY - Malesia 6
NI - Nicaragua 6
PT - Portogallo 6
UY - Uruguay 6
HR - Croazia 5
KE - Kenya 5
CR - Costa Rica 4
CY - Cipro 4
HN - Honduras 4
CH - Svizzera 3
GT - Guatemala 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
SV - El Salvador 3
AM - Armenia 2
BM - Bermuda 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
MK - Macedonia 2
MN - Mongolia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
TH - Thailandia 2
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
HU - Ungheria 1
KZ - Kazakistan 1
LR - Liberia 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
Totale 8.309
Città #
Singapore 365
Moscow 313
Ashburn 292
Hong Kong 279
Dallas 237
San Jose 216
New York 147
Beijing 136
Shanghai 120
Council Bluffs 109
Milan 106
Hefei 78
Los Angeles 76
Lauterbourg 68
Ho Chi Minh City 67
Lawrence 60
Princeton 59
Santa Clara 57
Rome 49
Boardman 48
São Paulo 44
Hanoi 38
Munich 38
Orem 36
Warsaw 33
Montreal 32
Denver 29
Chennai 27
Tokyo 27
Helsinki 26
London 25
Houston 22
Toronto 22
Atlanta 21
Nuremberg 21
Seattle 21
Cesano Boscone 20
Genoa 20
Poplar 20
Brooklyn 17
Mexico City 17
Stockholm 17
Guangzhou 16
Phoenix 16
Rio de Janeiro 14
Chicago 13
Naples 13
Turin 13
Turku 13
Boston 12
Da Nang 12
Johannesburg 11
Manchester 11
Tianjin 11
Verona 11
Washington 11
Buffalo 10
Catania 10
Figino 10
Mumbai 10
San Francisco 10
Wollongong 10
Amsterdam 9
Columbus 9
Falkenstein 9
Frankfurt am Main 9
Lahore 9
Miami 9
Ankara 8
Baghdad 8
Barnet 8
Bologna 8
Brisbane 8
Huskvarna 8
Istanbul 8
Pietra Ligure 8
The Dalles 8
Vienna 8
Belo Horizonte 7
Bogotá 7
Brussels 7
Curitiba 7
Kassel 7
Madrid 7
Sydney 7
Tashkent 7
Bari 6
Brasília 6
Haiphong 6
Hangzhou 6
Managua 6
Melbourne 6
Montevideo 6
Philadelphia 6
Pune 6
Querétaro 6
Riyadh 6
Calgary 5
Caruaru 5
Charlotte 5
Totale 3.963
Nome #
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 399
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 212
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 184
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 179
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study 160
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 156
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 154
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 153
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 153
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 152
Biobanking for COVID-19 research 149
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 147
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 145
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 135
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 133
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study 130
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 130
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 127
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 125
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 123
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 123
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 119
Subclinical myocardial dysfunction in patients recovered from COVID-19 117
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patients 116
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 114
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 114
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 111
Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci 111
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 108
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 107
Beneficial effects of cART initiated during primary and chronic HIV-1 infection on immunoglobulin-expression of memory B-cell subsets 106
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes 105
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 104
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 104
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 104
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience 103
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 102
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry 102
Comprehensive CT study to assess local and systemic involvement in patients with infective endocarditis: experience from a multidisciplinary team of a tertiary referral center 101
Ceftobiprole for the treatment of infective endocarditis: A case series 101
Role of Rehabilitation Department for Adult Individuals With COVID-19: The Experience of the San Raffaele Hospital of Milan 98
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 97
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 96
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report 92
How do I manage a patient with Stenotrophomonas maltophilia infection? 90
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 89
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19 89
Bowel perforation in a Covid-19 patient: case report 88
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 86
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 82
Estimated glomerular filtration rate trajectories in HIV-infected subjects treated with different ritonavir-boosted protease inhibitors and tenofovir disoproxil fumarate or abacavir 76
Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine 75
Immunosenescence and hurdles in the clinical management of older HIV-patients 72
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 72
Is shorter duration of antibiotic treatment feasible in patients with cardiac implantable electronic device infections undergoing device removal? A propensity-adjusted analysis of a 10-year retrospective cohort 71
Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy 70
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study) 70
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 70
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen 70
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis 70
Dynamics of adaptive and innate immunity inpatients treated during primary human immunodeficiency virus infection: Results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial 69
Maraviroc 150mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study 69
Short-term peripheral venous catheter-related bloodstream infections: Evidence for increasing prevalence of Gram-negative microorganisms from a 25-year prospective observational study 67
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 67
Eosinophils from Physiology to Disease: A Comprehensive Review 66
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study 64
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection 62
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa 62
Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis 62
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART 61
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 60
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections 60
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up 60
Immunological Recovery After 24 Weeks of Antiretroviral Therapy in Patients With X4 Virus During Primary HIV Infection 57
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients 56
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis-authors' response 56
Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient 56
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response 54
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 54
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 53
Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature 51
Rugarli. Medicina interna sistematica 50
Rugarli. Medicina interna sistematica 50
Bridging the gap in bloodstream infection management: A survey among non-infectious disease physicians 45
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research 37
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir 8
Monotherapy vs. combination therapy for Enterococcus faecalis bacteraemia: a target trial emulation 5
Regional sepsis care in Catalonia: comparative insights from a secondary analysis of the European Sepsis Care Survey 2
Totale 8.504
Categoria #
all - tutte 41.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.948


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022150 0 0 3 31 13 15 16 13 10 6 7 36
2022/2023482 136 113 22 9 20 63 16 52 14 10 17 10
2023/2024519 17 45 92 37 52 111 11 49 5 17 24 59
2024/20251.433 116 39 41 71 72 146 169 190 195 120 99 175
2025/20265.384 373 276 296 658 486 194 379 442 1.486 359 245 190
2026/2027469 185 284 0 0 0 0 0 0 0 0 0 0
Totale 8.504